# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-23-023115
Filing Date
2023-06-30
Accepted
2023-06-30 16:14:05
Documents
6
Period of Report
2023-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formpre14a.htm | PRE 14A | 303405
2 |  | pre14a_001.jpg | GRAPHIC | 15501
3 |  | pre14a_004.jpg | GRAPHIC | 1094
4 |  | proxy_001.jpg | GRAPHIC | 756220
5 |  | proxy_002.jpg | GRAPHIC | 581248
6 |  | proxy_003.jpg | GRAPHIC | 365769
| Complete submission text file | 0001493152-23-023115.txt |  | 2673658

Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37648 | Film No.: 231061863
SIC: 2835 In Vitro & In Vivo Diagnostic Substances